Why most extractables & leachables studies fail regulatory review-and how to fix them
Madhu of SG Pharma Solutions highlights why extractables and leachables (E&L) studies frequently fail regulatory review and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CII to host ‘Pillars of Protection’ conference in Hyderabad to address safety in pharma…
The event will highlight collaborative approaches to risk management, compliance, and technology integration for safer…
Eli Lilly shares results from QWINT trials on once-weekly insulin efsitora for type 2 diabetes
Efsitora met primary endpoints across three Phase 3 trials, showing comparable glucose control to daily basal insulin therapies
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3
In this final instalment, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech, transitions from analysis to action. Drawing on…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2
In this second part, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech continues the discussion on FDA expectations, with…
Biopharma innovation meets market headwinds tempering optimism: GlobalData
GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1
In the three-part series, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech in this article explores the evolution of India’s…
Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India
Through this agreement, Abbott will distribute MSD’s Januvia, Janumet, and Janumet XR across India to support diabetes management…
Alembic Pharmaceuticals receives USFDA EIR for API-III facility in Gujarat
The inspection at the Karakhadi-based manufacturing site was conducted by the USFDA from 17 to 21 March 2025
NEC and Chugai Pharmaceutical use AI to reduce drug combination prediction time for cancer…
Graph-based AI system developed by NEC may cut prediction time by 50%, offering support in identifying effective drug combinations…